During the average day medical professionals field around 25 clinical questions; generally, only a small percentage are ever pursued and even less are ever answered.
Max T. Baker, PhD, Founder and Associate Professor, Department of Anesthesia, University of Iowa Carver College of Medicine.
IDx is developing a new generation of diagnostic tools that are designed to benefit the health care system's entire spectrum of stakeholders.
Between 6-12 million needle-based procedures take place annually in the US. Unfortunately over 1,000 people die every year because of complications that arise from needle insertion. Inaccuracy during these procedures causes bleeding, serious infection, and collateral injuries.
PxAlpha is developing a revolutionary rotating shield brachytherapy device that selectively targets cancerous cells, with minimal side effects. Prostate cancer is the second most frequently diagnosed cancer in males, only behind skin cancer, with over 238,000 new cases every year.
Tansna Therapeutics, Inc., is a drug discovery and development company focused on novel therapies for the treatment of CNS disorders, with an initial focus on epilepsy. The company has identified a library of proprietary compounds that are derivatives of the marketed anesthetic propofol.
Virtual Systems Engineering (VSE) focuses on software for coordinating and integrating various aspects of printed-circuit-board (PCB) design and analysis.
Voxello, LLC provides methods, services, and devices to help caregivers more effectively communicate with their patients.Voxello has used over 25 years of clinical experience and research with severely disabled patients to create the Iowa Smart Switch, a device that allows patients, who are unabl